Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease

Citations Over TimeTop 1% of 2016 papers

Abstract

D-Amino acids, the enantiomers of L-amino acids, are increasingly recognized as novel biomarkers. Although the amounts of D-amino acids are usually very trace in human, some of them have sporadically been detected in blood from patients with kidney diseases. This study examined whether multiple chiral amino acids would be associated with kidney functions, comorbidities, and prognosis of chronic kidney disease (CKD) by enantioselective analyses of all chiral amino acids with a micro-two-dimensional high-performance liquid chromatograph (2D-HPLC)-based analytical platform. 16 out of 21 D-amino acids were detected in plasma from 108 CKD patients in a longitudinal cohort. The levels of D-Ser, D-Pro, and D-Asn were strongly associated with kidney function (estimated glomerular filtration ratio), the levels of D-Ala and D-Pro were associated with age, and the level of D-Asp and D-Pro were associated with the presence of diabetes mellitus. D-Ser and D-Asn were significantly associated with the progression of CKD in mutually-adjusted Cox regression analyses; the risk of composite end point (developing to ESKD or death before ESKD) was elevated from 2.7- to 3.8-fold in those with higher levels of plasma D-Ser and D-Asn. These findings identified chiral amino acids as potential biomarkers in kidney diseases.

Related Papers

• → BRAIN AMINO ACIDS(1980)10 cited
• → Selective photodestruction of α-amino acids(1978)1 cited
• Interactive Effects of Amino Acids in Aquatic Animal Feed(2015)
• Analysis on Main Genetic Components of Different Amino Acids in New Radiated Strains of Lentinus giganteus(2010)
• → P4‐123: Resolving Conflicting CSF Biomarker Information in Alzheimer′s Disease(2016)